Suzanne Somers' Cancer Battle And The Innovative Treatment That Retail Investors Can Support

Suzanne Somers died at age 76, but she'll long be remembered for her roles in the sitcoms "Three's Company" and "Step by Step" as well as her fitness business ventures.

But there's more to her legacy than that. For more than 40 years, Somers entertained people around the globe while battling cancer every step of the way.

Although her eventual cause of death was breast cancer, Somers fought many forms of the disease over the years. 

In her 20s, while on “Three’s Company,” she faced a condition called endometrial hyperplasia, a thickening of the uterine lining, which can sometimes lead to cancer.

In her 30s, Somers was diagnosed with melanoma, a dangerous type of skin cancer known for its ability to spread rapidly. Treatment for this often includes surgery, radiation and other therapies.

Don’t Miss:

• Until 2016 it was illegal for retail investors to invest in high-growth startups. Thanks to changes in federal law, this Kevin O’Leary-backed startup lets you become a venture capitalist with $100.
• It's only a matter of time before Autonomous Security Robots (ASRs) are on patrol near you. This industry leading company is offering up to $10M of bonds with 10% annual interest paid in cash.

Somers was first diagnosed with breast cancer in 2000, detected through a routine mammogram. She underwent a lumpectomy and radiation but declined chemotherapy.

By 2007, she was declared cancer-free and was on hormone treatments. The cancer returned in 2023, but she managed to achieve a cancer-free status once more, if even only for a short time.

Somers was not a fan of chemotherapy. In a 2009 interview, she talked about her alternative approach. 

While promoting her new book "Knockout," she said, "Cancer's an epidemic. And yet we keep going back to the same old pot because it's all we’ve got. Well, this is a book about options." 

Trending: Why You've Been Left Out Of The Insanely Profitable Business Of Website Flipping Until Now

Drawing from her personal experience, she emphasized the importance of having informed choices, which led her to experiment with bioidentical hormones as an alternative treatment option. 

Some people believe that alternative medicine is the right way to treat cancer, while others continue to push back. Somers was one of those who pushed back, and if her success in beating cancer for so long is any indication, she took the right route. 

No matter what side of the fence you sit on, it's good to know that there are companies taking a different approach to treating cancer. 

Starpax Biopharma Inc. is one such company. It has developed an innovative cancer treatment by integrating biochemistry, microbiology, electromagnetism engineering and artificial intelligence. Its Starpax Magnetodrones, which carry Food and Drug Administration (FDA)-approved anticancer drugs, are injected directly into tumors.

These Magnetodrones are guided precisely within the tumor by the unique magnetic fields of Starpax PolarTrak, ensuring the drugs target the tumor without entering the bloodstream, reducing typical side effects of systemic treatments. This approach provides three key benefits: local chemotherapy, therapy targeting low-oxygen stem cells and systemic immunotherapy. Retail investors can learn more about Starpax Biopharma here.

Read Next:

• With returns as high as 300%, it’s no wonder this asset is the investment choice of many billionaires. Uncover the secret.
• Be part of a groundbreaking journey to transform cancer treatment. Discover how a startup’s innovative approach aims to revolutionize the way we fight solid tumors.